Amneal Pharmaceuticals Inc
NYSE:AMRX
Amneal Pharmaceuticals Inc
NYSE:AMRX
Price:
6.775 USD
-1.38%
Updated:
May 16, 2024
Amneal Pharmaceuticals Inc
Operating Expenses
|
Amneal Pharmaceuticals Inc
Operating Expenses Peer Comparison
Comparables:
JNJ
BMY
PFE
MRK
LLY
Competitive Operating Expenses Analysis
Latest Figures & CAGR of Competitors
Latest Figures & CAGR of Competitors
| Company | Operating Expenses | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
|---|---|---|---|---|---|
|
|
Amneal Pharmaceuticals Inc
NYSE:AMRX
|
Operating Expenses
-$581.8m
|
CAGR 3-Years
-4%
|
CAGR 5-Years
-6%
|
CAGR 10-Years
-12%
|
|
|
Johnson & Johnson
NYSE:JNJ
|
Operating Expenses
-$35.3B
|
CAGR 3-Years
-1%
|
CAGR 5-Years
0%
|
CAGR 10-Years
-1%
|
|
|
Bristol-Myers Squibb Co
NYSE:BMY
|
Operating Expenses
-$24.1B
|
CAGR 3-Years
2%
|
CAGR 5-Years
-23%
|
CAGR 10-Years
-11%
|
|
|
Pfizer Inc
NYSE:PFE
|
Operating Expenses
-$28.2B
|
CAGR 3-Years
2%
|
CAGR 5-Years
2%
|
CAGR 10-Years
-2%
|
|
|
Merck & Co Inc
NYSE:MRK
|
Operating Expenses
-$39.8B
|
CAGR 3-Years
-27%
|
CAGR 5-Years
-17%
|
CAGR 10-Years
-8%
|
|
|
Eli Lilly and Co
NYSE:LLY
|
Operating Expenses
-$17.5B
|
CAGR 3-Years
-12%
|
CAGR 5-Years
-9%
|
CAGR 10-Years
-4%
|
See Also
What is Amneal Pharmaceuticals Inc's Operating Expenses?
Operating Expenses
-581.8m
USD
-581.8m
USD
Based on the financial report for Dec 31, 2023, Amneal Pharmaceuticals Inc's Operating Expenses amounts to -581.8m USD.
What is Amneal Pharmaceuticals Inc's Operating Expenses growth rate?
Operating Expenses CAGR 10Y
-12%
-12%
Over the last year, the Operating Expenses growth was 2%. The average annual Operating Expenses growth rates for Amneal Pharmaceuticals Inc have been -4% over the past three years , -6% over the past five years , and -12% over the past ten years .
You don't have any saved screeners yet
